产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 |
CAS No. |
79066-03-8 |
|---|---|
中文名称 |
(R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-羟基-10,13-二甲基-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-17-基)-N,N-二甲基戊酰胺 |
英文名称 |
(R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N,N-dimethylpentanamide |
别名 |
DMHCA;Chol-5-en-24-amide, 3-hydroxy-N,N-dimethyl-, (3β)- |
标准英文名 |
(R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N,N-dimethylpentanamide |
分子式 |
C26H43NO2 |
分子量 |
401.64 |
精确分子量 |
401.33 |
SMILES |
C[C@H](CCC(=O)N(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C |
标准SMILES |
C[C@H](CCC(=O)N(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C |
用途 |
DMHCA is a potent and selective LXR agonist that specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis; it exhibits anti-inflammatory effects and can be used in research on diabetic cholesterol homeostasis. |
InChIKey |
NDGUBXOBXSPVHJ-LXVLQKCJSA-N |
|
|
评论 |
|---|